Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report.

Abstract

Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis.

• Authors: Yoshiaki Murayama, Tomohiko Ishimine, Mikio Sasano, Takafumi Todaka, Takashi Matsumoto, Taiga Shimabukuro, Risa Yonaha
• Journal: IDCases (IDCases) Vol. 32 Pg. e01727 ( 2023) ISSN: 2214-2509 [Print] Netherlands
• PMID: 36896031 (Publication Type: Case Reports)
• Copyright: © 2023 The Authors.